Repligen | RGEN - 市值



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.27B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


市值 更改 日
Agilent USD 32.66B 5.2B 2026-03
Align Technology USD 12.08B 198M 2026-06
Bio Techne USD 11.35B 3.18B 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Bruker USD 8.3B 865M 2026-08
Charles River Laboratories USD 13.33B 2.94B 2026-08
Danaher USD 138.86B 10.4B 2026-06
Dentsply International USD 2.73B 605M 2026-08
General Electric Aerospace USD 389.93B 93.44B 2026-06
Henry Schein USD 11.26B 1.59B 2026-08
Illumina USD 26.71B 8.84B 2026-06
IQVIA Holdings USD 42.66B 10.41B 2026-08
Mettler Toledo International USD 25.82B 278M 2026-06
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 153.17B 14.73B 2026-08
Repligen USD 7.86B 168M 2026-08
Revvity USD 14.32B 1.63B 2026-08
Standard Biotools USD 359M 133M 2026-03
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
Waters USD 24.41B 12.83B 2026-08
West Pharmaceutical Services USD 25.36B 7.3B 2026-06